Anupam Rasayan India Ltd (NSE: ANURAS), a leading custom synthesis and specialty chemicals company, announced the signing of a long-term Supply Contract with a global major speciality metal manufacturer headquartered in the United States. This contract marks a significant step in Anupam Rasayan’s journey to diversify its customer base in the geological resource sector. The agreement entails the supply of a specialty chemical product to support the customer’s global operations, with dispatches expected to commence from the latter half of Q3 FY27.

Strategic Partnership

Speaking about the signed Supply Contract, Anand Desai, Managing Director of Anupam Rasayan, said: ‘This agreement is an important step in Anupam Rasayan’s journey to deepen our presence and diversify our customer base in the geological resource sector. This customer’s scale and leadership in their sector makes this an especially meaningful partnership for us. With the supplies under this contract spread over a six-year period, both companies see this as the beginning of a long-term relationship. We are confident that our manufacturing expertise, quality standards, and reliability will help us build lasting trust with our partner, and we look forward to a strong and enduring partnership in the years ahead.’

Company Overview

Anupam Rasayan India Ltd (Anupam) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the specialty chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Performance Materials comprising Electronics & EV Chemicals and Polymers. It operates via its eight manufacturing facilities, with six facilities located in Gujarat, one in Tamil Nadu, and one in the U.S. with an aggregate installed capacity of ~2,00,000+ MT as of March 31, 2026.

For further details please get in touch with:

Ms Sachi Yadav

Email: [email protected]

Phone: +91 98336 40764

Mr. Jigar Kavaiya

Email: [email protected]

Phone: +91 99206 02034

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Anupam Rasayan India Limited

Anupam Rasayan India Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Anupam moves sideways over three months, with neither buyers nor sellers taking control. The PEG stands at 4.24 — severely stretched. Any earnings miss could trigger a sharp de-rating. Thin margins at 6.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock gains 1.8% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 24.0% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Anupam Rasayan India Limited.

Anupam Rasayan India Limited (ANURAS) has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported consolidated revenue of Rs 6,675 Mn, up 36% year-on-year compared to Rs 4,907 Mn in Q1 FY26. The EBITDA (incl. other income) came in at Rs 1,749 Mn, up 35% YoY, translating into an EBITDA margin of 26.2% for Q1 FY27.

Key Financial Highlights

The company’s profit after tax stood at Rs 512 Mn in Q1 FY27 as compared to Rs 485 Mn in Q1 FY26, marking a 6% YoY growth. Commenting on the performance, Mr. Anand Desai, Managing Director, Anupam Rasayan India Limited, said, ‘We are pleased to begin fiscal year 2027 on a strong note. Consolidated revenue for the quarter grew 36% year-on-year, a result that reflects sustained momentum across our businesses and continued execution of our strategy to build a globally integrated specialty chemicals and CDMO platform.’

Technological Milestones

ANURAS also highlighted a significant technological milestone achieved during the quarter. The company became the first in the world to commercialize Ethyl Trifluoroacetate (ETFA) using flow chemistry, a notable advancement that further strengthens its capabilities in complex fluorination. Additionally, the company signed a Letter of Intent with BASQUEVOLT, S.A. for the potential long-term supply of a specialty chemical product, representing a revenue opportunity of approximately US$300 million spread over a period of ten years.

Looking ahead, Anupam Rasayan India Limited remains confident in its growth prospects. This confidence is supported by a strong product pipeline, expanding opportunities across its Performance Materials and Pharmaceuticals segments, deeper customer engagement, and continued investment in technology and innovation. Together, these initiatives position the company well to deliver sustainable growth and long-term value creation.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Anupam Rasayan India Limited

Anupam Rasayan India Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Anupam falls 12.2% over three months and has not found a floor yet. The PEG stands at 4.15 — severely stretched. Any earnings miss could trigger a sharp de-rating. Thin margins at 7.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock holds at 44% of its 52-week range with RSI at 33. In other words, neither side has a clear edge right now. The stock rises -12.2% in three months on 24.0% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Anupam Rasayan India Limited.

Anupam Rasayan India Ltd (NSE: ANURAS) announced on July 15, 2026, that it has signed a non-binding Letter of Intent (LOI) with Basquevolt, S.A., a European developer of solid-state lithium batteries. The LOI aims to explore the potential supply of a specialty chemical product over a period of up to 10 years for cumulative revenue of $300 million. This development marks a significant step forward in Anupam Rasayan’s strategy to deepen its footprint in the high-growth electronic chemicals space.

Strategic Expansion

Anand Desai, Managing Director of Anupam Rasayan, stated, ‘This LOI reinforces our strategic focus on expanding in the electronic chemical domain, which we believe will be a key growth driver going forward.’ Anupam Rasayan’s continued investments in R&D, process capabilities, and customer-centric innovation position it well to capture emerging opportunities in this space.

Company Background

Anupam Rasayan India Ltd is a leading custom synthesis and specialty chemicals company in India. Incorporated in 1984, the company has two verticals: Life science related Specialty Chemicals and Performance Materials. It operates six manufacturing facilities in Gujarat, India, with an aggregate installed capacity of about 30,000 MT as of March 31, 2026.

Looking Ahead

As the company moves forward with this potential supply agreement, it continues to leverage its strong R&D capabilities, quality standards, and ability to meet stringent customer requirements in specialized chemical formulations. This engagement underscores Anupam Rasayan’s commitment to catering to advanced manufacturing and technology-driven industries.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Anupam Rasayan India Limited

Anupam Rasayan India Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Anupam moves sideways over three months, with neither buyers nor sellers taking control. The PEG stands at 4.33 — severely stretched. Any earnings miss could trigger a sharp de-rating. Thin margins at 7.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock gains 1.1% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. The stock rises -1.9% in three months on 24.0% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Anupam Rasayan India Limited.